TABLE 1.
RBL-2H3 cells |
||||
---|---|---|---|---|
Rat brain | Stimulation | Elevation of [Ca2+]i | ||
Analoga | A3-receptors Ki (nM)b |
[3H]IP1 EC50c (µM) |
EC50d (µM) |
Relative efficacye |
2-CI-IBMECA | 0.33 | 4.1 ± 1 | 0.07 ± 0.04 | 60 |
IBMECA | 1.1 | 8.5 ± 1.7 | 0.11 ± 0.00 | 55 |
CHNECA | 16 | 12.2 ± 2.1 | 0.4 | 54 |
NECA | 113 | 2.1 ± 0.3 | 1.37 ± 0.18 | 100 |
APNEA | 116 | 7.5 ± 1.5 | 0.9 | 38 |
BZADO | 120 | 12.7 ± 2.6 | 2.7 | 60 |
R-PIA | 158 | 5.5 ± 0.9 | 2.4 | 38 |
CHA | 167 | 11.6 ± 1.1 | 0.88 ± 0.00 | 30 |
CGS 21680 | 584 | 5.8 ± 0.6 | 0.79 ± 0.02 | 28 |
ADO | ~1,000 | 11.8 ± 1.1 | 1.45 ± 0.25 | 72 |
2-CIADO | 1890 | 8.1 ± 1.5 | 1.7 | 25 |
8-BrADO | >100,000 | 13.9 ± 1.0 | Inactive |
Abbreviations in legend to Fig. 1.
Data from Gallo-Rodriguez et al. (1994), Van Galen et al. (1994), and Jacobson et al. (1995).
EC50 values determined from data of Fig. 1A.
EC50 values determined from data such as that presented in Fig. 4. Values are means ± s.e.m. (n = 3) or are from single determinations.
Efficacies relative to NECA set equal to 100 estimated from data such as those presented in Fig. 4.